Search
Search Results
##search.searchResults.foundPlural##
-
SOLITARY PLASMACYTOMA
4204PDF: 2248HTML: 1407fIGURES 1,2: 256 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1294PDF: 747HTML: 1261 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4942PDF: 1866HTML: 2868Untitled: 255 -
SICKLE CELL ANAEMIA AND MALARIA
11821PDF: 7293HTML: 24044Figures Malaria and SCK: 251 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4065PDF: 1102HTML: 3901Untitled: 192Cneo. Fig.1: 129Untitled: 124Untitled: 149Untitled: 158 -
THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS
3004PDF: 1047HTML: 115 -
PREVALENCE OF SERIOUS BACTERIAL INFECTIONS IN CHILDREN WITH SICKLE CELL DISEASE AT KING ABDULAZIZ HOSPITAL, AL AHSA Bacterial infections in children with sickle cell diseas
1701PDF: 673HTML: 288 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8260PDF: 4460HTML: 7571 -
Spontaneous rupture of malarial spleen: report of two cases
869PDF: 424HTML: 2889jdoe, cover letter.doc: 196 -
-
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3268PDF: 1180HTML: 1687Untitled: 206Untitled: 196Untitled: 193 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2336PDF: 861HTML: 1702Figure 1: 230Table 1: 241 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2248PDF: 1629HTML: 685 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1976HTML: 1667PDF: 1163 -
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
3345PDF: 1162HTML: 7748cover letter paper final AML: 245 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2678PDF: 849HTML: 5379 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1916PDF: 841HTML: 233 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2347PDF: 926HTML: 2018Fig 1 Rossi: 223 -
-
IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis
1104PDF: 748HTML: 277 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4698PDF: 2001HTML: 18167 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3802PDF: 1152HTML: 2476Figure 1: 230 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
5117PDF: 2004HTML: 11456Fig 1: 258Fig 2: 214Fig 3: 339Fig 4: 216Fig 5: 223Fig 6: 214Fig 7: 233Fig 8: 213 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1647PDF: 883HTML: 1082Picture 1: 192 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2129PDF: 865HTML: 1105 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
1025PDF: 609Html: 310Suppl. Files: 196 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1541HTML: 662PDF: 886 -
-
PROPHYLAXIS OF MALARIA
3107PDF: 1079HTML: 17995Figures SChwartz: 189 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2830PDF: 995HTML: 637 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1786PDF: 777HTML: 2354 -
The diagnostic pitfalls of mucormycosis
1027PDF: 749HTML: 292







